CLDX stock

Celldex Therapeutics Inc (CLDX) financials · $2.35B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Celldex Therapeutics Inc (CLDX) $2.35B cap.

Cached income statement (latest stored periods)
LineQ2 2026Q1 2026
Revenue$22.0K$15.0K
Operating Income-$80.6M-$84.4M
Net Income-$73.5M-$78.7M
EPS (Diluted)-$0.94-$1.18
Cached balance sheet (latest stored periods)
LineQ2 2026Q1 2026
Total Assets$782.3M$511.3M
Current Assets$724.9M$459.2M
Cash & Equivalents$47.5M$35.7M
PP&E$9.76M$7.40M
Total Liabilities$67.8M$55.0M
Current Liabilities$61.3M$51.5M
Shareholders' Equity$714.6M$456.2M
Retained Earnings-$1.97B-$1.89B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$210.9M-$157.8M
CapEx$2.71M$1.92M
Investing Cash Flow$209.1M-$290.1M
Financing Cash Flow$2.39M$441.4M
Net Change in Cash$515.0K-$6.46M
Free Cash Flow-$213.7M-$159.7M
These statements as JSON? API free 100/day

FAQ

What is CLDX P/E and revenue?

Celldex Therapeutics Inc (CLDX) $2.35B cap.

What is CLDX revenue?

Celldex Therapeutics Inc last cached revenue is $22.0K (Q2 2026).

Is CLDX profitable?

Celldex Therapeutics Inc last cached net income is -$73.5M (Q2 2026).

What are CLDX total assets?

Celldex Therapeutics Inc last cached total assets are $782.3M (Q2 2026).

What is CLDX free cash flow?

Celldex Therapeutics Inc last cached free cash flow is -$213.7M (FY2025).

Not investment advice. Cached statements, not a live tape.